TABLE 2.
Antimicrobial | FASTvet panel concentrations (μg/ml) |
|||||
Phenotype | S | I | R | S (urine) | R (urine) | |
Gram negative bacilli | Ampicillin | ≤0.25 | 0.5 | >0.5 | ≤8 | >8 |
Amoxicillin-clavulanic acid | ≤0.25/0.12 | 0.5/0.25 | >0.5/0.25 | ≤8/4 | >8/4 | |
Piperacillin-tazobactam* | ≤16/4 | 64/4 | >64/4 | |||
Cefpodoxime | ≤2 | 4 | >4 | |||
Imipenem* Enterobacterales | ≤1 | 2 | >2 | |||
Imipenem* Pseudomonas spp. | ≤2 | 4 | >4 | |||
Enrofloxacin Enterobacterales | ≤0.12 | 0.25 | >0.25 | |||
Enrofloxacin Pseudomonas spp. | ≤0.5 | 2 | >2 | |||
Gentamicin | ≤2 | 4 | >4 | |||
Amikacin | ≤4 | 8 | >8 | |||
Staphylococcus spp. | Penicillin* | ≤0.12 | >0.12 | |||
Cefoxitin* | ≤4 | >4 | ||||
Enrofloxacin | ≤0.5 | 2 | >2 | |||
Vancomycin* S. aureus | ≤2 | 8 | >8 | |||
Enterococcus spp. | Vancomycin* S. coagulase neg | ≤4 | 16 | >16 | ||
Ampicillin* | ≤8 | >8 | ||||
Vancomycin* | ≤4 | 16 | >16 |
*Human breakpoints. According to flow cytometry analysis when the cells show lesions with the lowest concentration tested, the strain is considered S (susceptible); if no lesion is shown with the lower concentration and but only with the second concentration, the strain is considered I (intermediate); if even with the highest concentration no effect is seen, the strain is considered R (resistant). The category of I is not always present.